Day: April 21, 2020
Westport, CT, April 21, 2020 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”) today announced that on April 16, 2020 its subsidiary ViralClear Pharmaceuticals, Inc. submitted an application for Vicromax(tm_ (merimepodib, or MMPD) through the FDA’s Coronavirus Treatment Acceleration Program (CTAP) to administer the drug to hospitalized patients with COVID-19.On March 31, 2020, the FDA created the Coronavirus Treatment Acceleration Program (CTAP), a special emergency program for possible therapies, using every available method to move new treatments to patients as quickly as possible. The FDA continues to support clinical trials that are testing new treatments for COVID so that they gain valuable knowledge about their safety and effectiveness.“We believe that submitting an application through...
Kallelse till årsstämma i Arcoma Aktiebolag (publ)
Written by Customer Service on . Posted in Public Companies.
Kallelse till årsstämma i Arcoma Aktiebolag (publ)Aktieägarna i Arcoma Aktiebolag (publ), org. nr 556410-8198, kallas härmed till årsstämma i bolagets lokaler på Annavägen 1 i Växjö onsdagen den 20 maj 2020 kl. 13:00.Rätt att delta och anmälanAktieägare som önskar delta i bolagsstämman skavara införd i den av Euroclear Sweden AB förda aktieboken torsdagen den 14 maj 2020 ochanmäla sig till bolaget senast torsdagen den 14 maj 2020 skriftligen till Arcoma Aktiebolag, Koncernledning, Annavägen 1, 352 46 Växjö. Anmälan kan också göras per telefon 0470-70 69 13 eller per e-post service@arcoma.se. I anmälan ska uppges fullständigt namn, person- eller organisationsnummer, aktieinnehav, adress, telefonnummer dagtid samt ska, i förekommande fall, uppgift om antal biträden (högst två) lämnas.Förvaltarregistrerade aktierAktieägare som har sina aktier...
Nymox Announces Important New Patent Developments
Written by Customer Service on . Posted in Public Companies.
HASBROUCK HEIGHTS, N.J., April 21, 2020 (GLOBE NEWSWIRE) — Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to announce the recent allowances of 4 new different US and international patents concerning the Company’s prostate enlargement and prostate cancer treatments. The new US and international patents that have been allowed are further expansions of Nymox’s intellectual property covering the Company’s prostate treatment technologies.Nymox CEO, Dr Paul Averback stated, “Intellectual property is one of the backbones of the biopharmaceutical industry. We are therefore very pleased to report that another 4 patents have recently been allowed. During the past year a total of 10 new patents have been allowed which adds to the Company’s very strong intellectual property position for the future. Nymox continues...
IPG Leads the Industry on Ad Age A-List
Written by Customer Service on . Posted in Public Companies.
McCann Worldgroup and Weber Shandwick Named to Top 10R/GA Named Comeback Agency of the YearMediahub is Media Agency of the YearFCB Named a Standout AgencyThe Martin Agency Named Agency to WatchNew York, April 21, 2020 (GLOBE NEWSWIRE) — Interpublic Group (NYSE: IPG) announced today that with six of its agencies honored by Ad Age on its A-List and related rankings, the company leads the industry in terms of number of agencies recognized on the trade publication’s prestigious annual ranking of the industry’s top marketing and communications agencies. McCann Worldgroup and Weber Shandwick were named among the top 10, with R/GA Named Comeback Agency of the Year and Mediahub named Media Agency of the Year. FCB was named a Standout Agency, and The Martin Agency was listed as an Agency to Watch.“We are always proud of our agencies and the...
CRCAM Alpes Provence : Mise à disposition du Rapport Financier 2019
Written by Customer Service on . Posted in Public Companies.
Communiqué Information réglementéeAix-en-Provence, le 21 avril 2020 CRCAM Alpes Provence Mise à disposition du Rapport Financier Annuel 2019Le Crédit Agricole Alpes Provence vous informe que le document est disponible sur son site Internet : www.ca-alpesprovence.fr et a été transmis à l’Autorité des Marchés Financiers.Lien direct : https://www.credit-agricole.fr/ca-alpesprovence/particulier/informations/informations-reglementees.html NYSE Euronext Paris – Eurolist compartiment C – ISIN : FR0000044323Responsable de l’Information Financière : Jérôme VUILLEMOT (Directeur Financier)E-mail : jerome.vuillemot@ca-alpesprovence.frL’ensemble des informations réglementées sont disponibles sur le site internet www.ca-alpesprovence.frPièce jointeCRCAM ALPES PROVENCE – Mise à disposition Rapport Financier annuel 2019
HQGE and 1oneninety5 Introduces All-Star Executive Management Hollywood Dream Team
Written by Customer Service on . Posted in Public Companies.
LOS ANGELES, CA, April 21, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE ‒ HQ Global Education, Inc. (OTC: HQGE) and its operating subsidiary 1oneninety5 have released the names and credentials of the first four new members of 1oneninety5’s executive management team. Upon making the announcement, Leah Daniels-Butler, President of HQGE and 1oneninety5, stated, “I could not be more pleased that this ‘Hollywood Dream Team’ of four highly experienced and well-respected industry professionals have chosen to come aboard and help lead 1oneninety5 to becoming what we believe will be the finest and most successful new minority-owned entertainment company in the industry. We welcome these four as core leaders of our team, and we expect to be adding additional members very soon, as well.”The newly appointed slate includes:Keith Price, Chief Financial...
PAVmed Receives FDA 510(k) Clearance for its CarpX™ Minimally Invasive Carpal Tunnel Device
Written by Customer Service on . Posted in Public Companies.
NEW YORK, April 21, 2020 (GLOBE NEWSWIRE) — PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced it has received 510(k) marketing clearance from the U.S. Food and Drug Administration (FDA) for its CarpX™ minimally invasive carpal tunnel device.The FDA determined that CarpX is “substantially equivalent to legally marketed predicates” and that PAVmed may market CarpX for “the minimally invasive isolation and incision/division of ligaments, tendons, or fascia such as the transverse carpal ligament for treatment of carpal tunnel syndrome.” The FDA reached this determination after reviewing detailed data from the Company’s successful CarpX clinical safety study performed in New Zealand.“We are very excited to introduce CarpX as the first 510(k)-cleared...
Taronis Fuels Ships First Gasification Unit to Ankara
Written by Customer Service on . Posted in Public Companies.
$5 Million in Revenue Recognized in AprilPHOENIX, AZ, April 21, 2020 (GLOBE NEWSWIRE) — Taronis Fuels, Inc., (“Taronis” or “the Company”) (OTC: TRNF), a global producer of renewable and socially responsible fuel products, today provided an update on the status of a key contract with a client based in Turkey. On April 21, 2020, the Company successfully shipped a 50KW mobile Venturi plasma arc gasification unit to fulfill an existing purchase order. The unit was previously announced as a $5 million sale to a reseller and marketing partner in the industrial sales and marketing space based in Turkey with its primary offices in Ankara, and regional offices in Dusseldorf, Germany. The unit is currently scheduled to arrive in Turkey in May. The unit will be shipped in two phases, with the first shipping via Miami, Florida on April 21,...
Juniper Networks为Deutsche Telekom提供托管SD-WAN平台以为其企业客户提供端到端叠加服务
Written by Customer Service on . Posted in Public Companies.
加州森尼韦尔, April 21, 2020 (GLOBE NEWSWIRE) — 安全人工智能驱动网络领先企业Juniper Networks(NYSE:JNPR)与世界领先的一家跨制造商数字服务提供商T-Systems携手合作,共同打造并交付作为端到端叠加解决方案一部分的托管SD-WAN基础设施,以满足一些公司的复杂网络和连接性需求。通过这项服务,T-Systems专注于采用具备安全托管平台的现代企业网络,提供多云托管应用,以及提供诸如托管SD-WA叠加服务(称为Smart SD-WAN)等标准化服务。由Juniper提供技术支持的Smart SD-WAN是先进、安全的网络基础设施的基石,而这一基础设施是T-Systems数字化转型战略的基础。在业已获得欧洲某主要交通品牌作为上述服务的旗舰客户之后,T-Systems预计其产品将为范围广泛的企业提供一项令人信服的主张,为其业务带来可观收入。T-Systems的最终目标是致力于通过降低复杂性、有效管理成本和提高数据保护能力,帮助企业客户实现数字化转型。此外,作为核心业务资产,为客户提供对网络的更高可见性可帮助他们更轻松地实现数字化目标。 新闻亮点:为打造这项全新服务,T-Systems集成了一系列Juniper产品,包括:Contrail Service Orchestration:一个可扩展的多租户软件平台,可提供自动化分支连接管理,让T-Systems能够改善网络服务交付,在提供可靠性和灵活性的同时,延展整个多云网络上的可见性。SRX系列安全网关:一系列SD-WAN客户终端设备,提供全面的分层安全服务,可针对已知和未知的威胁实现高级防御。NFX系列网络服务平台:安全、符合标准的CPE设备,可让T-Systems为客户轻松创建并提供网络服务。vSRX虚拟防火墙:提供与Juniper的SRX系列实体防火墙相同的功能,但采用虚拟化形式以提供可扩展的安全服务,使得T-Systems可在端对端多云SD-WAN服务中添加云站点。所有Juniper基础设施均在Junos®操作系统上运行,并针对全新云时代的网络所需的模块化、开放性和可编程性进行了Junos体验优化。Junos的设计追求可靠性、安全性和灵活性,可在提高运行效率的同时实现网络运行自动化。这是一套全面的联网安全机制,包括防火墙用户身份验证、应用安全、统一威胁管理以及入侵检测和预防系统,用以增强网络防御功能。Juniper联网安全平台在整个网络上提供上述及其他功能,以自动保护用户和数据。客户评价:“在我们看来,定制连接性是客户数字化和业务成功的基本因素。通过与Juniper合作,我们能够为企业客户提供端到端、面向需求的基础设施,以支持他们应对数字化挑战并降低网络中的复杂性。Juniper的创新解决方案让我们能够通过具有技术和财务竞争力的解决方案,提供高度灵活且充满活力的服务。” –...
瞻博網絡 (Juniper Networks) 向 Deutsche Telekom 提供受管 SD-WAN 平台,藉此為其企業客戶提供端到端覆蓋服務
Written by Customer Service on . Posted in Public Companies.
加利福尼亞州桑尼維爾, April 21, 2020 (GLOBE NEWSWIRE) — 瞻博網絡 (Juniper Networks,NYSE: JNPR) 是安全及由人工智能驅動網絡的領導者,最近與世界領先的跨製造商數碼服務供應商之一 T-Systems 合作建立及帶來一個受管 SD-WAN 基礎架構,以作為端對端服務覆蓋解決方案的一部分,為要求複雜網絡和連接的公司提供服務。透過此服務,T-Systems 致力於採用具有安全受管平台的現代企業網絡,以帶來多雲端託管應用程式,並提供標準化服務作為受管 SD-WAN 覆蓋服務,稱為 Smart SD-WAN。Smart SD-WAN 由瞻博網絡提供支持,是一個先進而安全的網絡基礎架構的基石,也是 T-Systems 數碼化轉型策略的基礎。T-Systems 已經獲得一個歐洲主要運輸品牌作為這些服務的旗艦客戶,現正預期產品能為多家企業提供有意思的提議,為其業務帶來可觀的收入。最終,T-Systems 致力於透過降低複雜性、有效管理成本和提高數據保護能力來幫助其企業客戶回應數碼化轉型。此外,公司為客戶提供更大的網絡可見度以作為客戶的核心業務資產,從而協助他們更輕鬆地實現其數碼目標。 新聞摘要:為建立此新產品供應,T-Systems 整合了一系列瞻博網絡產品,包括:Contrail Service Orchestration – 這是一個可擴展的多租戶軟件平台,提供自動化的分支機構連接管理,讓 T-Systems 得以改善網絡服務交付,提供可靠性和敏捷性,同時擴大其多雲端網絡的可見度。SRX 系列安全閘道器 – 這是一系列 SD-WAN 客戶場地裝置,提供全面的分層安全服務套件,可對已知和未知威脅實施進階防禦。NFX 系列網絡服務平台 – 這是一個安全且符合標準的 CPE 裝置,讓 T-Systems 得以輕鬆地為其客戶建立及交付網絡服務。vSRX 虛擬防火牆 – 此產品提供與瞻博實物 SRX...